Cargando…
Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
[Image: see text] While vaccine development will hopefully quell the global pandemic of COVID-19 caused by SARS-CoV-2, small molecule drugs that can effectively control SARS-CoV-2 infection are urgently needed. Here, inhibitors of spike (S) mediated cell entry were identified in a high throughput sc...
Autores principales: | Chen, Catherine Z., Xu, Miao, Pradhan, Manisha, Gorshkov, Kirill, Petersen, Jennifer D., Straus, Marco R., Zhu, Wei, Shinn, Paul, Guo, Hui, Shen, Min, Klumpp-Thomas, Carleen, Michael, Samuel G., Zimmerberg, Joshua, Zheng, Wei, Whittaker, Gary R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586456/ https://www.ncbi.nlm.nih.gov/pubmed/33330839 http://dx.doi.org/10.1021/acsptsci.0c00112 |
Ejemplares similares
-
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2021) -
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2022) -
The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators
por: Gorshkov, Kirill, et al.
Publicado: (2020) -
Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein
por: Petersen, Jennifer D., et al.
Publicado: (2022) -
The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles
por: Petersen, Jennifer D., et al.
Publicado: (2022)